GSK3117391 / Chroma Therap, GSK  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK3117391 / GSK
NCT02965599 / 2015-005800-27: Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK3117391 in Subjects With Rheumatoid Arthritis

Terminated
2
3
Europe
GSK3117391, Placebo
GlaxoSmithKline
Arthritis, Rheumatoid
11/17
11/17

Download Options